Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first quarter of 2024.
- Net revenue was $982 million in the first quarter, which is down 4% as reported, and 6% in constant currency from Q1 2023
- Overall organic net revenue decreased by 8% year-over-year during the three-month period
- The company reported a net loss of $715 million for the September quarter, including non-cash goodwill impairment charges of $700 million
- On a per-share basis, Q1 loss was $3.94, vs. breakeven in the year-ago quarter
- Q1 adjusted net loss was $19 million or $0.10 per share, compared to adjusted profit of $61 million or $0.34 per share last year
- Adjusted EBITDA came in at $115 million, down 38% as reported, and 39% in constant currency, compared to last year
- For fiscal 2024, the company expects net revenue to be in the range of $4.30 billion to $4.50 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%
